AUPH · Aurinia Pharmaceuticals Inc. · Investor Relations
$16.74
+0.25 (+1.52%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$2.22B
Shares
133.05M
Volume · Oct 20
593.6K
Avg daily vol (3M)
966.28K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-02-26 | Fourth Quarter and Full Year 2025 Financial Results Conference Call | Earnings call |
| 2025-11-04 | Third Quarter 2025 Financial Results Conference Call | Earnings call |
| 2025-07-31 | Second Quarter 2025 Financial Results Conference Call | Earnings call |
| 2025-06-30 | Conference Call to Discuss Positive Results from Phase 1 Study of Aritinercept (AUR200) | Earnings call |
| 2025-05-21 | LUPUS 2025, the 16th International Congress on SLE | Webcast |
Key facts
CIK
1600620
CUSIP
05156V102
13F (30d)
19 filings
19 filers
Visit website
Investor relations